JPH10509052A - ヒドロゲル・パッチ - Google Patents
ヒドロゲル・パッチInfo
- Publication number
- JPH10509052A JPH10509052A JP9506016A JP50601697A JPH10509052A JP H10509052 A JPH10509052 A JP H10509052A JP 9506016 A JP9506016 A JP 9506016A JP 50601697 A JP50601697 A JP 50601697A JP H10509052 A JPH10509052 A JP H10509052A
- Authority
- JP
- Japan
- Prior art keywords
- gel
- patch
- hydrogel
- water
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 title claims description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 93
- 239000000463 material Substances 0.000 claims abstract description 88
- 102000004190 Enzymes Human genes 0.000 claims abstract description 72
- 108090000790 Enzymes Proteins 0.000 claims abstract description 72
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 69
- 239000008103 glucose Substances 0.000 claims abstract description 69
- 239000000872 buffer Substances 0.000 claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 30
- 239000003792 electrolyte Substances 0.000 claims abstract description 12
- 239000000499 gel Substances 0.000 claims description 188
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 69
- 229940088598 enzyme Drugs 0.000 claims description 69
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 46
- 239000004366 Glucose oxidase Substances 0.000 claims description 35
- 108010015776 Glucose oxidase Proteins 0.000 claims description 35
- 229940116332 glucose oxidase Drugs 0.000 claims description 35
- 235000019420 glucose oxidase Nutrition 0.000 claims description 35
- 229920002125 Sokalan® Polymers 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 24
- 239000011780 sodium chloride Substances 0.000 claims description 24
- 239000012491 analyte Substances 0.000 claims description 23
- 238000004132 cross linking Methods 0.000 claims description 23
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 22
- 239000002250 absorbent Substances 0.000 claims description 22
- 230000002745 absorbent Effects 0.000 claims description 22
- 238000009792 diffusion process Methods 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 238000005259 measurement Methods 0.000 claims description 14
- 238000004806 packaging method and process Methods 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000004584 polyacrylic acid Substances 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 239000007795 chemical reaction product Substances 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 2
- 150000002433 hydrophilic molecules Chemical class 0.000 claims 4
- 230000000887 hydrating effect Effects 0.000 claims 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 47
- 239000000080 wetting agent Substances 0.000 abstract description 12
- 239000003139 biocide Substances 0.000 abstract description 10
- 239000004971 Cross linker Substances 0.000 abstract description 6
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 150000003839 salts Chemical class 0.000 description 21
- 239000000126 substance Substances 0.000 description 20
- 239000002253 acid Substances 0.000 description 15
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 12
- 239000003431 cross linking reagent Substances 0.000 description 12
- 239000002202 Polyethylene glycol Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 238000010894 electron beam technology Methods 0.000 description 9
- -1 hydrogen ions Chemical class 0.000 description 9
- 239000008363 phosphate buffer Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 7
- 239000008273 gelatin Substances 0.000 description 7
- 229920000159 gelatin Polymers 0.000 description 7
- 235000019322 gelatine Nutrition 0.000 description 7
- 235000011852 gelatine desserts Nutrition 0.000 description 7
- 239000000174 gluconic acid Substances 0.000 description 7
- 235000012208 gluconic acid Nutrition 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 6
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000011343 solid material Substances 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000001627 detrimental effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229940051250 hexylene glycol Drugs 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000005865 ionizing radiation Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- KFSLWBXXFJQRDL-UHFFFAOYSA-N peroxyacetic acid Substances CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 description 2
- UCBVELLBUAKUNE-UHFFFAOYSA-N 1,3-bis(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)NC(=O)N(CC=C)C1=O UCBVELLBUAKUNE-UHFFFAOYSA-N 0.000 description 2
- MZGMQAMKOBOIDR-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCO MZGMQAMKOBOIDR-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000011850 desserts Nutrition 0.000 description 2
- 238000011026 diafiltration Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- YIKSHDNOAYSSPX-UHFFFAOYSA-N 1-propan-2-ylthioxanthen-9-one Chemical compound S1C2=CC=CC=C2C(=O)C2=C1C=CC=C2C(C)C YIKSHDNOAYSSPX-UHFFFAOYSA-N 0.000 description 1
- GTELLNMUWNJXMQ-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;prop-2-enoic acid Chemical class OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.CCC(CO)(CO)CO GTELLNMUWNJXMQ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 101100008050 Caenorhabditis elegans cut-6 gene Proteins 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 241001467460 Myxogastria Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000004772 Sontara Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 102000020006 aldose 1-epimerase Human genes 0.000 description 1
- 108091022872 aldose 1-epimerase Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 150000001845 chromium compounds Chemical class 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- UKASIOIEWZDBIT-UHFFFAOYSA-N phenyl-(2,3,4-trimethylphenyl)methanone Chemical compound CC1=C(C)C(C)=CC=C1C(=O)C1=CC=CC=C1 UKASIOIEWZDBIT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/0436—Material of the electrode
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Colloid Chemistry (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Light Guides In General And Applications Therefor (AREA)
- Prostheses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.(a)水の存在下においてゲルを形成する親水性化合物であって、ヒドロゲルの 重量に対して、約4%またはそれ以上の重量で存在する化合物、 (b)ヒドロゲルの重量に対して約95%またはそれ未満の量で存在する水、 (c)反応を触媒する能力を有する酵素、および (d)電解質、 を含むヒドロゲル・パッチ。 2.ゲル中の背景信号が約200nA未満である、請求項1記載のヒドロゲル・パッチ 。 3.段階(c)における反応の産物が、30分以内に20%より多く分解されることのな い、請求項1記載のヒドロゲル・パッチ。 4.段階(c)の反応において反応する分析物の拡散が律速的であって、分析物の拡 散が測定時間よりも迅速である、請求項1記載のヒドロゲル・パッチ。 5.ヒドロゲルが選択されたヒドロゲル環境を維持するための成分をさらに含み 、該環境が、分析物の段階(c)における反応産物への変換を増強させるような、 請求項1記載のヒドロゲル・パッチ。 6.酵素がグルコースと酸素との反応を触媒し、その結果として電子が生成され る、請求項1記載のヒドロゲル・パッチ。 7.(e)ヒドロゲル中のpHを約3〜9の範囲に維持するために十分な量の緩衝剤をさ らに含む、請求項6記載のヒドロゲル・パッチ。 8.親水性化合物が、ポリエチレン酸化物、ポリアクリル酸、ポリビニルアルコ ール、カルボポール(Carbopol)(登録商標)およびポリアクリルアミドメチル プロパンスルホネートならびにその共重合体からなる群より選択され、 電解質がNaClおよびKClからなる群より選択され、 酵素がグルコースオキシダーゼであり、グルコースオキシダーゼの量が段階(a )における吸収材および段階(b)における水溶液の合計重量1g当たり10単位〜5000 単位の範囲で存在し、 該水溶液が、吸収材パッチのpHを約3〜9の範囲に維持するために十分な量の緩 衝剤を水中に溶解された形でさらに含む、請求項1記載のヒドロゲル・パッチ。 9.親水性化合物が、ヒドロゲルの重量に対して、約40%未満の重量で存在し、 水 が約60%より多い重量で存在する、請求項1記載のヒドロゲル・パッチ。 10.厚さが約5μmから約60ミルの範囲である平坦な形状を特徴とする、請求項1 記載のヒドロゲル・パッチ。 11.第1および第2の表面領域を特徴とし、それぞれの表面領域が約0.5cm2から約 10cm2の範囲であり、パッチの厚さが約5μmから10ミルの範囲である、請求項10 記載のヒドロゲル・パッチ。 12.ヒドロゲル中に埋め込まれた構造支持性材料をさらに含み、該構造支持性材 料がヒドロゲル・パッチと実質的に同じ外部パラメーター外形およびサイズを有 する不織布である、請求項1記載のヒドロゲル・パッチ。 13.(a)乾燥酵素がその中に埋め込まれた吸収材、および (b)その中に電解質が溶解されている水溶液を含み、力を加えることによって破 壊されるシールによって吸収材から分離されており、さらにシールが破壊された 後に吸収材から直ちに脱着することができる、吸収材の第1の表面に接着した包 装容器、 を有することを特徴とする吸収材パッチ。 14.吸収材が第1および第2の表面領域を有し、各表面領域が約0.5cm2から約10cm2 の範囲であり、厚さが約5μmから約50ミルの範囲である、請求項13記載の吸収 材パッチ。 15.第1の表面および第2の表面上に存在するリリースライナーと、水の位置を保 持させる材料が埋め込まれた不織材料とをさらに含む、請求項14記載のパッチ。 16.ヒトの皮膚に適合するよう十分な柔軟性を有することを特徴とし、ヒトの皮 膚に接着するがゲルを除去した際に触知しうるゲルの残渣を皮膚上に残さないよ うな、請求項14記載のパッチ。 17.(a)乾燥したゲル成分とゲル混合物を形成する量の水とを混合する段階と、 (b)水和されたゲルを形成するためゲル混合物を架橋する段階と、 (c)水和されたケルを固体支持体へ接着させる段階と、 (d)固体支持体上のゲルを乾燥させる段階であって、該乾燥したゲル成分が、親 水性化合物が水和されたゲルの重量に対して約4%またはそれ以上の重量で存在 する、水の存在下でゲルを形成する親水性化合物、反応を触媒する能力を有する 酵素 および電解質を含み、水和されたゲルの重量に対して水の量が約95%またはそれ 未満である段階、 とを含む方法によって調製される、固体支持体上の乾燥ゲルパッチ。
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50166495A | 1995-07-12 | 1995-07-12 | |
| US08/501,664 | 1995-07-12 | ||
| US501,664 | 1995-07-12 | ||
| PCT/US1996/011675 WO1997002811A1 (en) | 1995-07-12 | 1996-07-11 | Hydrogel patch |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10509052A true JPH10509052A (ja) | 1998-09-08 |
| JP3201482B2 JP3201482B2 (ja) | 2001-08-20 |
Family
ID=23994518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50601697A Expired - Lifetime JP3201482B2 (ja) | 1995-07-12 | 1996-07-11 | ヒドロゲル・パッチ |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0840597B1 (ja) |
| JP (1) | JP3201482B2 (ja) |
| KR (1) | KR19990028884A (ja) |
| AT (1) | ATE250928T1 (ja) |
| AU (1) | AU706662B2 (ja) |
| CA (1) | CA2226176C (ja) |
| DE (1) | DE69630226T2 (ja) |
| DK (1) | DK0840597T3 (ja) |
| ES (1) | ES2208754T3 (ja) |
| PT (1) | PT840597E (ja) |
| WO (1) | WO1997002811A1 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007108505A1 (ja) * | 2006-03-22 | 2007-09-27 | Chugai Seiyaku Kabushiki Kaisha | エリスロポエチン溶液製剤 |
| JP2012068263A (ja) * | 2000-03-17 | 2012-04-05 | Sontra Medical Inc | 体液の非侵襲性のサンプリングおよび分析のためのシステム、方法およびデバイス |
| JP2020115103A (ja) * | 2019-01-18 | 2020-07-30 | 国立大学法人山形大学 | 汗成分センサ |
| KR20220008571A (ko) * | 2020-07-14 | 2022-01-21 | 주식회사 피씨지바이오 | 생체적합성 하이드로겔을 포함하는 온도 감응형 복합 하이드로겔 시트 |
| JP2022519587A (ja) * | 2019-02-08 | 2022-03-24 | チトゲル リミテッド | 外科用ハイドロゲル |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024059A1 (en) | 1995-12-28 | 1997-07-10 | Cygnus, Inc. | Continuous monitoring of physiological analyte |
| US5954685A (en) * | 1996-05-24 | 1999-09-21 | Cygnus, Inc. | Electrochemical sensor with dual purpose electrode |
| US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US6139718A (en) * | 1997-03-25 | 2000-10-31 | Cygnus, Inc. | Electrode with improved signal to noise ratio |
| US6503198B1 (en) * | 1997-09-11 | 2003-01-07 | Jack L. Aronowtiz | Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods |
| AU2002300167B2 (en) * | 1997-09-11 | 2006-08-31 | Jack L. Aronowitz | Noninvasive Transdermal Systems for Detecting Analytes |
| US7066884B2 (en) | 1998-01-08 | 2006-06-27 | Sontra Medical, Inc. | System, method, and device for non-invasive body fluid sampling and analysis |
| US8287483B2 (en) | 1998-01-08 | 2012-10-16 | Echo Therapeutics, Inc. | Method and apparatus for enhancement of transdermal transport |
| CA2265119C (en) | 1998-03-13 | 2002-12-03 | Cygnus, Inc. | Biosensor, iontophoretic sampling system, and methods of use thereof |
| DE69902229T2 (de) | 1998-05-13 | 2003-02-20 | Cygnus, Inc. | Sammelvorrichtungen für transdermale probennahmesysteme |
| US6180416B1 (en) | 1998-09-30 | 2001-01-30 | Cygnus, Inc. | Method and device for predicting physiological values |
| DK1102559T3 (da) | 1998-09-30 | 2003-09-29 | Cygnus Therapeutic Systems | Fremgangsmåde og anordning til forudsigelse af fysiologiske værdier |
| JP2002528190A (ja) | 1998-10-28 | 2002-09-03 | シグナス, インコーポレイテッド | イオン導入サンプリングシステムの品質管理試験のためのキットおよび方法 |
| US20040171980A1 (en) | 1998-12-18 | 2004-09-02 | Sontra Medical, Inc. | Method and apparatus for enhancement of transdermal transport |
| US6561978B1 (en) | 1999-02-12 | 2003-05-13 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
| US7577469B1 (en) | 1999-03-11 | 2009-08-18 | Jack L. Aronowitz | Noninvasive transdermal systems for detecting an analyte in a biological fluid and methods |
| KR100535261B1 (ko) * | 1999-03-29 | 2005-12-09 | 주식회사 태평양 | 하이드로젤 매트릭스 점착시트형 화장료 |
| WO2000064533A1 (en) * | 1999-04-22 | 2000-11-02 | Cygnus, Inc. | Methods and devices for removing interfering species |
| WO2002015777A1 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Methods and devices for prediction of hypoglycemic events |
| WO2002017210A2 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
| US20020026111A1 (en) | 2000-08-28 | 2002-02-28 | Neil Ackerman | Methods of monitoring glucose levels in a subject and uses thereof |
| IL138788A0 (en) * | 2000-09-29 | 2001-10-31 | Falk Fish | Method and kit for the transdermal determination of analyte concentration in blood |
| KR100732948B1 (ko) * | 2000-11-22 | 2007-06-27 | 아이큐어 주식회사 | 국소마취용 패취 |
| ES2357318T3 (es) | 2002-03-22 | 2011-04-25 | Animas Technologies Llc | Mejora del rendimiento de un dispositivo monitorizador de analito. |
| AU2003222985B2 (en) * | 2002-04-24 | 2008-07-24 | Archimed Llp | Wound dressings comprising hydrated hydrogels and enzymes |
| US7150975B2 (en) | 2002-08-19 | 2006-12-19 | Animas Technologies, Llc | Hydrogel composition for measuring glucose flux |
| GB0313217D0 (en) | 2003-06-09 | 2003-07-16 | Insense Ltd | Improvements in or relating to skin dressings |
| GB2403146B (en) * | 2003-06-23 | 2007-07-11 | Johnson & Johnson Medical Ltd | Method of making a wound dressing comprising lactate oxidase |
| KR20060082852A (ko) | 2003-08-15 | 2006-07-19 | 애니머스 테크놀로지스 엘엘씨 | 생리적 분석물의 모니터링용 마이크로 프로세서, 장치, 및방법 |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US7105588B2 (en) | 2003-10-10 | 2006-09-12 | E. I. Du Pont De Nemours And Company | Screen printable hydrogel for medical applications |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| GB0427444D0 (en) * | 2004-01-30 | 2005-01-19 | Insense Ltd | Improvements relating to skin dressings |
| WO2005072784A1 (en) * | 2004-01-30 | 2005-08-11 | Insense Limited | Wound dressings comprising hydrated hydrogels and enzymes |
| US8224414B2 (en) | 2004-10-28 | 2012-07-17 | Echo Therapeutics, Inc. | System and method for analyte sampling and analysis with hydrogel |
| JP4903414B2 (ja) * | 2005-01-19 | 2012-03-28 | シスメックス株式会社 | 分析物抽出カートリッジセットおよび分析方法 |
| US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
| US7432069B2 (en) | 2005-12-05 | 2008-10-07 | Sontra Medical Corporation | Biocompatible chemically crosslinked hydrogels for glucose sensing |
| GB2441784A (en) * | 2006-09-13 | 2008-03-19 | Rtc North Ltd | Device for obtaining and analysing a biological fluid |
| WO2008109739A1 (en) | 2007-03-07 | 2008-09-12 | Echo Therapeutics, Inc. | Transdermal analyte monitoring systems and methods for analyte detection |
| CA2685423C (en) | 2007-04-27 | 2014-02-18 | Echo Therapeutics, Inc. | Skin permeation device for analyte sensing or transdermal drug delivery |
| KR101468579B1 (ko) * | 2008-03-24 | 2014-12-03 | 아이큐어 주식회사 | 약물 또는 활성물질의 안정성을 향상시키는 속용성 필름조성물, 속용성 필름 제제 및 이를 이용한이온영동패취세트 |
| KR101101321B1 (ko) * | 2008-11-03 | 2012-01-02 | 주식회사 엠씨티티 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
| JP5572016B2 (ja) | 2009-08-04 | 2014-08-13 | シスメックス株式会社 | 組織液抽出用デバイス、その製造方法、及び該デバイスを用いた組織液の分析方法 |
| WO2011041463A2 (en) | 2009-09-30 | 2011-04-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
| EP2861267A4 (en) * | 2012-06-15 | 2016-01-20 | Agentase Llc | INTELLIGENT, SELF-DECONTAMINATING POLYMER AND METHOD FOR INHIBITING THE GROWTH OF BACTERIA AND MUSHROOMS |
| KR101296105B1 (ko) * | 2013-01-04 | 2013-08-19 | 김동춘 | 하이드로겔화된 부직포, 이의 제조방법, 및 이를 이용한 마스크 팩 |
| US20140275817A1 (en) * | 2013-03-13 | 2014-09-18 | Guardit Technologies, Llc | Portable, Pediatric Medical Diagnostic Device |
| JP6411066B2 (ja) * | 2014-05-12 | 2018-10-24 | ユニ・チャーム株式会社 | 吸収体用の不織布シートを含む吸収性物品、及び当該吸収性物品に用いられる不織布シートの製造方法 |
| WO2018078562A1 (en) | 2016-10-26 | 2018-05-03 | Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies (A4Tec) | Fibers with segments, their preparation and applications thereof |
| US10561441B2 (en) | 2016-12-05 | 2020-02-18 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with an umbrella member for structural support |
| US10448970B2 (en) | 2016-12-05 | 2019-10-22 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with telescoping central support element |
| KR101895037B1 (ko) | 2016-12-15 | 2018-09-04 | 주식회사 제닉 | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 |
| KR101895038B1 (ko) | 2016-12-15 | 2018-09-04 | 주식회사 제닉 | 스피큘을 포함하는 용해성 필름 및 이의 용도 |
| CN107495961A (zh) * | 2017-09-25 | 2017-12-22 | 北京海思瑞格科技有限公司 | 心电电极及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362307A (en) * | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
| KR970011449B1 (ko) * | 1988-01-29 | 1997-07-11 | 더 리전트 오브 디 유니버시티 오브 캘리포니아 | 이온전기 영동형 비침입 검체 채취 또는 이송 장치 및 방법 |
| EP0363504A1 (en) | 1988-10-10 | 1990-04-18 | Dräger Nederland B.V. | Method of providing a substrate with a layer comprising a polyvinylbased hydrogel and a biochemically active material |
| CA2193885C (en) * | 1994-06-24 | 2003-11-25 | Janet Tamada | Iontophoretic sampling device and method |
-
1996
- 1996-07-11 DK DK96924493T patent/DK0840597T3/da active
- 1996-07-11 AT AT96924493T patent/ATE250928T1/de not_active IP Right Cessation
- 1996-07-11 ES ES96924493T patent/ES2208754T3/es not_active Expired - Lifetime
- 1996-07-11 WO PCT/US1996/011675 patent/WO1997002811A1/en not_active Ceased
- 1996-07-11 PT PT96924493T patent/PT840597E/pt unknown
- 1996-07-11 EP EP96924493A patent/EP0840597B1/en not_active Expired - Lifetime
- 1996-07-11 DE DE69630226T patent/DE69630226T2/de not_active Expired - Lifetime
- 1996-07-11 CA CA002226176A patent/CA2226176C/en not_active Expired - Lifetime
- 1996-07-11 KR KR1019980700186A patent/KR19990028884A/ko not_active Ceased
- 1996-07-11 AU AU64928/96A patent/AU706662B2/en not_active Ceased
- 1996-07-11 JP JP50601697A patent/JP3201482B2/ja not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012068263A (ja) * | 2000-03-17 | 2012-04-05 | Sontra Medical Inc | 体液の非侵襲性のサンプリングおよび分析のためのシステム、方法およびデバイス |
| WO2007108505A1 (ja) * | 2006-03-22 | 2007-09-27 | Chugai Seiyaku Kabushiki Kaisha | エリスロポエチン溶液製剤 |
| JP2020115103A (ja) * | 2019-01-18 | 2020-07-30 | 国立大学法人山形大学 | 汗成分センサ |
| JP2022519587A (ja) * | 2019-02-08 | 2022-03-24 | チトゲル リミテッド | 外科用ハイドロゲル |
| KR20220008571A (ko) * | 2020-07-14 | 2022-01-21 | 주식회사 피씨지바이오 | 생체적합성 하이드로겔을 포함하는 온도 감응형 복합 하이드로겔 시트 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0840597A1 (en) | 1998-05-13 |
| JP3201482B2 (ja) | 2001-08-20 |
| DE69630226D1 (de) | 2003-11-06 |
| WO1997002811A1 (en) | 1997-01-30 |
| AU706662B2 (en) | 1999-06-17 |
| CA2226176A1 (en) | 1997-01-30 |
| EP0840597B1 (en) | 2003-10-01 |
| PT840597E (pt) | 2004-02-27 |
| KR19990028884A (ko) | 1999-04-15 |
| CA2226176C (en) | 2003-09-16 |
| ATE250928T1 (de) | 2003-10-15 |
| ES2208754T3 (es) | 2004-06-16 |
| DE69630226T2 (de) | 2004-08-05 |
| DK0840597T3 (da) | 2004-01-26 |
| AU6492896A (en) | 1997-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10509052A (ja) | ヒドロゲル・パッチ | |
| WO1997002811A9 (en) | Hydrogel patch | |
| JP5354502B2 (ja) | 過酸化水素送達システム | |
| US20070190122A1 (en) | Skin dressings | |
| US20040062759A1 (en) | Hydrogel formulations for use in electroosmotic extraction and detection of glucose | |
| RU2527341C2 (ru) | Лечение инфекции поверхности тела человека или животного | |
| CA2688101C (en) | Multi-layer pad and methods of using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080622 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090622 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100622 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110622 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110622 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120622 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120622 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130622 Year of fee payment: 12 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |